Huaren Pharmaceutical: 15% compound amino acid injection (17AA) approved for clinical trials

Summary: Huaren Pharmaceutical disclosed that its 15% compound amino acid injection (17AA) had been approved for clinical trials, and it will have a clinical study for two years.Huaren Pharmaceutical Co., Ltd. (Huaren Pharmaceutical) announced on 3 J...

Amino Acids China E-News 201707

www.cnchemicals.com